1. Home
  2. RNTX vs WBX Comparison

RNTX vs WBX Comparison

Compare RNTX & WBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNTX

Rein Therapeutics Inc.

HOLD

Current Price

$0.97

Market Cap

80.7M

Sector

Health Care

ML Signal

HOLD

Logo Wallbox N.V.

WBX

Wallbox N.V.

HOLD

Current Price

$4.08

Market Cap

65.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNTX
WBX
Founded
2001
2015
Country
United States
Spain
Employees
10
696
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
80.7M
65.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RNTX
WBX
Price
$0.97
$4.08
Analyst Decision
Buy
Buy
Analyst Count
2
4
Target Price
$10.00
$4.75
AVG Volume (30 Days)
583.4K
106.8K
Earning Date
05-15-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$18.10
Revenue Next Year
N/A
$94.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$0.29
52 Week High
$2.18
$7.83

Technical Indicators

Market Signals
Indicator
RNTX
WBX
Relative Strength Index (RSI) 45.08 69.80
Support Level N/A $2.61
Resistance Level $1.33 $4.94
Average True Range (ATR) 0.09 0.37
MACD 0.01 0.13
Stochastic Oscillator 55.14 85.29

Price Performance

Historical Comparison
RNTX
WBX

About RNTX Rein Therapeutics Inc.

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments: Europe, the Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

Share on Social Networks: